Mirae Asset Global Etfs Holdings Ltd. Biotechnology

Mirae Asset Global Etfs Holdings Ltd.

$43.9 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
FHTX Foghorn Therapeutics Inc.	$162M	$68,000 0.0% of portfolio	14,472	Q4 2024 Added 4.39%
TCRX T Scan Therapeutics, Inc.	$26.9M	$67,000 0.0% of portfolio	22,214	Q4 2024 Added 4.45%
ENTA Enanta Pharmaceuticals Inc	$113M	$65,000 0.0% of portfolio	11,471	Q4 2024 Added 4.94%
BMEA Biomea Fusion, Inc.	$58.6M	$61,000 0.0% of portfolio	15,829	Q4 2024 Added 4.52%
RGLS Regulus Therapeutics Inc.	$115M	$57,000 0.0% of portfolio	36,701	Q4 2024 Added 4.4%
CABA Cabaletta Bio, Inc.	$37.1M	$55,000 0.0% of portfolio	25,446	Q4 2024 Added 8.01%
SAVA Cassava Sciences Inc	$64.2M	$54,000 0.0% of portfolio	23,294	Q4 2024 Added 4.43%
IGMS Igm Biosciences, Inc.	$37.4M	$53,000 0.0% of portfolio	8,706	Q4 2024 Added 4.56%
VERU Veru Inc.	$40.9M	$49,000 0.0% of portfolio	75,747	Q4 2024 Added 4.51%
BDTX Black Diamond Therapeutics, Inc.	$57.1M	$48,000 0.0% of portfolio	22,766	Q4 2024 Added 11.95%
LXRX Lexicon Pharmaceuticals, Inc.	$136M	$48,000 0.0% of portfolio	65,782	Q4 2024 Added 4.49%
APLT Applied Therapeutics Inc.	$19.2M	$46,000 0.0% of portfolio	55,108	Q4 2024 Reduced 6.63%
NAUT Nautilus Biotechnology, Inc.	$86M	$46,000 0.0% of portfolio	27,878	Q4 2024 Added 4.56%
TNYA Tenaya Therapeutics, Inc.	$19.9M	$45,000 0.0% of portfolio	31,660	Q4 2024 Added 4.52%
XBIT X Biotech Inc.	$85.2M	$44,000 0.0% of portfolio	11,390	Q4 2024 Added 12.17%
PYXS Pyxis Oncology, Inc.	$37.6M	$43,000 0.0% of portfolio	28,011	Q4 2024 Added 4.54%
LCTX Lineage Cell Therapeutics, Inc.	$78.1M	$42,000 0.0% of portfolio	84,709	Q4 2024 Added 4.5%
ABOS Acumen Pharmaceuticals, Inc.	$41.3M	$41,000 0.0% of portfolio	24,079	Q4 2024 Added 4.62%
GLSI Greenwich Life Sciences, Inc.	$122M	$39,000 0.0% of portfolio	3,482	Q4 2024 Added 4.56%
HLVX Hille Vax, Inc.	$64.5M	$37,000 0.0% of portfolio	18,480	Q4 2024 Added 4.29%
INMB Inmune Bio, Inc.	$131M	$36,000 0.0% of portfolio	7,728	Q4 2024 Added 13.5%
OVID Ovid Therapeutics Inc.	$20.4M	$33,000 0.0% of portfolio	35,530	Q4 2024 Added 4.24%
PEPG Pep Gen Inc.	$36.2M	$33,000 0.0% of portfolio	8,899	Q4 2024 Added 4.46%
ALXO Alx Oncology Holdings Inc	$22.4M	$31,000 0.0% of portfolio	18,913	Q4 2024 Added 4.62%
GBIO Generation Bio Co.	$24.2M	$30,000 0.0% of portfolio	28,709	Q4 2024 Added 4.42%
STTK Shattuck Labs, Inc.	$39.4M	$27,000 0.0% of portfolio	22,697	Q4 2024 Added 4.55%
IPSC Century Therapeutics, Inc.	$33M	$26,000 0.0% of portfolio	26,277	Q4 2024 Added 4.54%
RAPT Rapt Therapeutics, Inc.	$27M	$26,000 0.0% of portfolio	17,073	Q4 2024 Added 4.66%
HOWL Werewolf Therapeutics, Inc.	$27.8M	$26,000 0.0% of portfolio	17,871	Q4 2024 Added 4.44%
ATNM Actinium Pharmaceuticals, Inc.	$36M	$21,000 0.0% of portfolio	17,073	Q4 2024 Added 4.66%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$20,000 0.0% of portfolio	7,742	Q4 2024 Added 4.09%
ELEV Elevation Oncology, Inc.	$8.16M	$16,000 0.0% of portfolio	28,029	Q4 2024 Added 5.02%
GALT Galectin Therapeutics Inc	$76.7M	$13,000 0.0% of portfolio	11,705	Q4 2024 Added 4.76%
PRLD Prelude Therapeutics Inc	$29.5M	$9,000 0.0% of portfolio	7,575	Q4 2024 Added 4.18%
LYRA Lyra Therapeutics, Inc.	$3.82M	$5,000 0.0% of portfolio	27,770	Q4 2024 Added 4.58%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	33,560	Q4 2024 Added 11.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.